
Ohglip MP 1mg/500mg/15mg Tablet
Marketer
Orenburg Healthcare Pvt. Ltd.
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Ohglip MP 1mg/500mg/15mg Tablet
Metformin/Glimepiride/Pioglitazone 1mg/500mg/15mg tablets offer a combined approach to managing elevated blood glucose. This medication, used alongside a healthy diet and regular physical activity, improves glycemic control in adult patients with type 2 diabetes. It enhances insulin effectiveness, leading to reduced blood sugar. Always adhere to your physician's prescribed dosage and regimen for Metformin/Glimepiride/Pioglitazone 1mg/500mg/15mg tablets. Take it with food to minimize gastrointestinal discomfort. If a dose is missed, take it immediately unless the next dose is imminent; in that case, skip the missed dose and resume your usual schedule. Never double the dose. Excessive intake may result in dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol, or skipped meals elevates the risk of hypoglycemia. Regular blood glucose monitoring is crucial. Other potential side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Kidney function tests will be conducted before treatment initiation. Limit alcohol consumption to mitigate the risk of adverse reactions.
Primary Ingredients of Ohglip MP 1mg/500mg/15mg Tablet
No text provided to rephrase.
Uses of Ohglip MP 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Ohglip MP 1mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. The Ohglip MP 1mg/500mg/15mg tablet should be administered with a meal.
Common Side effects of Ohglip MP 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Ohglip MP 1mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Ohglip MP 1mg/500mg/15mg tablet should be administered with a meal.
How Ohglip MP 1mg/500mg/15mg Tablet works:
Ohglip MP 1mg/500mg/15mg tablets contain glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their combined action improves blood sugar management when single or dual drug regimens prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Ohglip MP 1mg/500mg/15mg tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Ohglip MP 1mg/500mg/15mg tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Employing Ohglip MP 1mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Ohglip MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Ohglip MP 1mg/500mg/15mg tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should use Ohglip MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Ohglip MP 1mg/500mg/15mg tablets are contraindicated in patients exhibiting severe liver disease.
What if you forget to take Ohglip MP 1mg/500mg/15mg Tablet :
Should you forget to take your Ohglip MP 1mg/500mg/15mg Tablet, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Ohglip MP 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
